LYSARC is an independent, non-profit organization.
It conducts its research activities in accordance with the Charter of the relations between the French Cooperative Groups in Oncology, of which LYSARC is part of, and industry. The charter can be consulted at:
The protection of patients is a top priority for LYSARC. We submit our study protocols and informed consent forms to cancer patient committees, in cooperation with the French Ligue Against Cancer and according to the recommendations of France’s 2014-2019 Cancer Plan. Our data and biological collections are declared in compliance with regulations.
Our studies in progress are posted on different specialized websites, including that of the US National Institute of Health and the LYSA website. Active trials can also been found on the online application ClinTrial Refer LYSA.